|Statement||by Dirk Böcker, Lars Eckardt, Günter Breithardt|
|Series||Clinical approaches to tachyarrhythmias -- v. 18|
|Contributions||Eckardt, Lars, Breithardt, Günter, Wiley online library|
|LC Classifications||RD598 .B625 2004eb|
|The Physical Object|
|Format||[electronic resource] /|
Implantation of defibrillators has evolved dramatically since its introduction by Mirowski in Since the first implantation, a huge body of information on the impact of implantable cardioverter Read more. A stepwise testing protocol for modern implantable cardioverter-defibrillator systems to prevent pacemaker-implantable cardioverter-defibrillator interactions. Am J Cardiol ; Mattke S, Markewitz A, Müller D, et al. The combined transvenous implantation of cardioverter defibrillators and permanent pacemakers. Indications for implantable cardioverter-defibrillator (ICD) implant can be divided into two broad categories: secondary prophylaxis against sudden cardiac death and primary prophylaxis. Implantable Cardioverter Defibrillator (ICD) ICDs are useful in preventing sudden death in patients with known, sustained ventricular tachycardia or fibrillation. Studies have shown ICDs to have a role in preventing cardiac arrest in high-risk patients who haven't had, but are at risk for, life-threatening ventricular arrhythmias.
Current Problems in Cardiology Vol Issue 6, June , Pages The implantable cardioverter defibrillator: technology, indications, and impact on cardiovascular survival ☆. The wearable cardioverter-defibrillator vest: Indications and ongoing questions. Multiple clinical trials have demonstrated the efficacy of implantable cardioverter-defibrillators (ICDs) for the prevention of sudden cardiac death (SCD) among specific high-risk populations. The current clinical indications for WCD use are varied and. NCD Implantable Cardiac Defibrillators (ICDs) MLN Matters Number: SE The current requirements for reporting heart failure codes (ICD diagnosis codes I, I, I, I, I, and I) for patients with ischemic or nonischemic - qualify for an Automatic Implantable Cardioverter Defibrillator (AICD) but. Current Indications for the Implantable Cardioverter Defibrillator (Clinical Approaches To Tachyarrhythmias) (1st Edition) by Gunter Breithardt, Lars Eckardt M.D., Dirk Bã Cker, Dirk Böcker, Dirk Bocker M.D., Günter Breithardt Paperback, Pages, Published ISBN / ISBN / Need it Fast? 2 day shipping options.
An implantable cardioverter defibrillator (ICD) is the preferred therapy for prevention of SCD in HCM patients. The recommended indications are as follows: ICD can be used for secondary prevention in survivors of cardiac arrest or sustained VT. Background Recent clinical trials and advances in device technology have expanded the indications for implantable cardioverter-defibrillators (ICDs).At le ICDs are implanted per month in the US and over 3 million patients in North America are eligible for an ICD. Near the end of life, however, ICD decision-making can be the source of anguish for patients, families and palliative care. Current Indications for the Implantable Cardioverter Defibrillator Dirk Böcker, Lars Eckardt, Gunter Breithardt ISBN: September Wiley-Blackwell Pages. Introduction. Several new indications for the implantable cardioverter defibrillator (ICD) have been established in recent years. 1–6 If all patients eligible for ICD implantation actually receive them, the cardiology workforce performing ICD controls will face massive additional workload with insufficient resources. 7 Moreover, unexpected ICD failures because of electronic or lead defects.